# US 2012/0252876 A1 · Trans-acting rna switches

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252876 A1
- Document ID: US20120252876A1
- Status: Published application
- Kind: A1
- Application number: 13/321,816
- Filed: 2010-05-21
- Published: 2012-10-04
- Earliest claimed: 2009-05-22
- Assignees: The Research Foundation of the University of New York
- Inventors: Scott A. Tenenbaum; Francis J. Doyle, II; Ajish George; Christopher Zaleski
- Web page: https://patentgrep.com/patent/US20120252876A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- C12N 2310/113: targeting other non-coding nucleic acids, e.g. antagomirs
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/531: Stem-loop; Hairpin
- C12N 2320/50: Methods for regulating/modulating their activity
- C12N 2330/51: Specially adapted vectors
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Disclosed are RNA constructs which function to activate or inactivate a biological process, e.g., may be designed for attachment to a polypeptide coding region. Such RNA constructs modulate translation of a polypeptide from the coding region in response to the presence of a target polynucleotide in an expression environment. Such RNA constructs include a weakened stem-loop structure which, when bound to the target polynucleotide, assumes stem-loop secondary structure and associates with an RNA binding protein. Association with the RNA binding protein modulates translation of the polypeptide coding region. Such RNA constructs also have three-way junction joining regions 3′ and 5′ of the stem-loop structure.

## Claims

### Claim 1

An RNA construct comprising a non-naturally occurring, continuous sequence of ribonucleotide bases defining:
a stem-loop structure;
simulated, three way junction joining regions 3′ and 5′ of the stem-loop structure;
a first region 5′ of the 5′ joining region comprising bases complementary to a 3′ region of a target polynucleotide;
a second region 3′ of the 3′ joining region comprising bases complementary to a 5′ region of the target polynucleotide;
the base sequence of the first and second regions being selected to hybridize with complementary bases on the target polynucleotide spaced apart by an intermediate region on the target polynucleotide defining another three way junction joining region, whereby,
in the presence of the target polynucleotide, a stem-loop conformation of said construct is stabilized.

### Claim 2 (depends on 1)

The construct of claim 1, wherein at least one base in the stem of the stem-loop structure is mismatched with its potential binding partner so as to reduce the stability of the stem-loop conformation.

### Claim 3 (depends on 1)

The construct of claim 1 wherein the RNA construct further comprises RNA defining a polypeptide coding region and wherein
in the absence of the target polynucleotide, the construct assumes a conformation inhibiting association with an RNA binding protein and suppressing translation of the polypeptide-coding region, and
in the presence of the target polynucleotide, the construct assumes a stem-loop conformation promoting association with the RNA binding protein and promoting translation of the polypeptide coding region.

### Claim 4 (depends on 3)

The construct of claim 3 wherein the polypeptide coding region is disposed 5′ of the first region.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The construct of claim 1, wherein the target polynucleotide is characteristic of a pathogen.

### Claim 7 (depends on 6)

The construct of claim 6 wherein the pathogen is a virus or a single-celled microorganism.

### Claim 8 (depends on 1)

The construct of claim 1, wherein the target polynucleotide is expressed preferentially in a cell type of a multicellular organism.

### Claim 9 (depends on 8)

The construct of claim 8 wherein the cell type is a neoplastic cell.

### Claim 10 (depends on 1)

The construct of claim 1, wherein the target polynucleotide comprises a synthetic target polynucleotide or ssDNA for transfection into a cell.

### Claim 11 (depends on 1)

A DNA vector comprising a transcription unit encoding a construct as in claim 1.

### Claim 12 (depends on 1)

A cell comprising a construct as in claim 1.

### Claim at position 13

-29. (canceled)

### Claim 30

A method for modulating translation of a polypeptide coding region comprising the step of:
(A) providing a translatable RNA construct comprising a polypeptide coding region ligated to a non-naturally occurring RNA comprising a continuous sequence of ribonucleotide bases, the continuous sequence of ribonucleotide bases defining:
a stem-loop structure which associates with an RNA binding protein present in an expression environment to modulate translation of the polypeptide coding region when the RNA construct is in a stem-loop conformation;
simulated, three way junction joining regions 3′ and 5′ of the stem-loop structure;
a first region 5′ of the 5′ joining region comprising bases complementary to a 3′ region of a target polynucleotide;
a second region 3′ of the 3′ joining region comprising bases complementary to a 5′ region of the target polynucleotide;
the base sequence of the first and second regions being selected to hybridize with complementary bases on the target polynucleotide spaced apart by an intermediate region on the target polynucleotide defining another three way junction joining region; and
(B) introducing the translatable RNA construct into an expression system, whereby,
in the absence of the target polynucleotide, the construct assumes a conformation inhibiting association with the RNA binding protein, and
in the presence of the target polynucleotide, the construct assumes a stem-loop conformation promoting association with the RNA binding protein.

### Claim 31 (depends on 30)

The method of claim 30, wherein at least one base in the stem of the stem-loop structure is mismatched with its potential binding partner so as to reduce the stability of the stem-loop structure.

### Claim 32

(canceled)

### Claim 33 (depends on 30)

The method of claim 30, wherein step (B) is effected by transfecting a DNA encoding the translatable RNA construct.

### Claim 34 (depends on 30)

The method of claim 30, wherein the target polynucleotide is characteristic of a pathogen.

### Claim 35 (depends on 30)

The method of claim 30, the target polynucleotide is expressed preferentially in a cell type of a multicellular organism.

### Claim 36 (depends on 35)

The method of claim 35 wherein the cell type is a neoplastic cell.

### Claim at position 21

-40. (canceled)

### Claim 41 (depends on 30)

The method of claim 30, wherein the polypeptide coding region encodes a detectable marker.

### Claim 42 (depends on 41)

The method of claim 41, wherein the detectable marker is fluorescent.

### Claim 43 (depends on 30)

The method of claim 30, wherein translation of the coding region is suppressed when the RNA binding protein binds to the stem-loop structure.

### Claim 44 (depends on 30)

The method of claim 30, wherein translation of the coding region is promoted when the RNA binding protein binds to the stem-loop structure.

### Claim 45 (depends on 30)

The method of claim 30, wherein the construct comprises more than one stem-loop structure.

### Claim 46

A method of killing preferentially, in a heterogeneous population of animal cells, target cells that harbor a single-stranded target polynucleotide having a known sequence, the method comprising the step of:
introducing into the heterogeneous cell population an RNA construct attached to a polypeptide coding region which encodes a polypeptide lethal to the target cells and for modulating translation of the polypeptide coding region in response to the presence of the target single-stranded polynucleotide in the target cells, the RNA construct comprising a non-naturally occurring, continuous sequence of ribonucleotide bases defining:
a stem-loop structure which associates with an RNA binding protein present in the target cells to promote translation of the polypeptide coding region when the construct is in a stem-loop conformation;
simulated, three way junction joining regions 3′ and 5′ of the stem-loop structure;
a first region 5′ of the 5′ joining region comprising bases complementary to a 3′ region of the target polynucleotide;
a second region 3′ of the 3′ joining region comprising bases complementary to a 5′ region of the target polynucleotide;
the base sequence of the first and second regions being selected to hybridize with complementary bases on the target polynucleotide spaced apart by an intermediate region on the target polynucleotide defining another three way junction joining region, whereby,
in cells where the target polynucleotide is absent, the construct assumes a conformation inhibiting association with the RNA binding protein and suppressing translation of the coding region, and
in cells where the target polynucleotide is present, the construct assumes a stem-loop conformation promoting association with the RNA binding protein and promoting translation of the coding region thereby to kill target cells.

### Claim 47 (depends on 46)

The method of claim 46, wherein at least one base in the stem of the stem-loop structure is mismatched with its potential binding partner so as to reduce the stability of the stem-loop conformation.

### Claim 48

(canceled)

### Claim 49 (depends on 46)

The method of claim 46, wherein the target polynucleotide is characteristic of a pathogen.

### Claim 50 (depends on 49)

The method of claim 49 wherein the pathogen is a virus or a single-celled microorganism.

### Claim 51 (depends on 46)

The method of claim 46, wherein the target polynucleotide is expressed preferentially in a target cell type of a multicellular organism.

### Claim 52 (depends on 51)

The method of claim 51 wherein the target cell type is a neoplastic cell type.

### Claim 53 (depends on 51)

The method of claim 51 wherein the target cell is an infected cell or a neoplastic cell, and the target polynucleotide is expressed by the an organism infecting the cell or by the neoplastic cell.

### Claim 54 (depends on 46)

The method of claim 46, wherein the polypeptide coding region comprises a sequence encoding an enzyme or pore-forming protein.

### Claim at position 36

-57. (canceled)
